Recommended immunization schedule for children and adolescents: Committee on infectious diseases of the korean pediatric society, 2018
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, E.H. | - |
dc.contributor.author | Park, S.E. | - |
dc.contributor.author | Kim, Y.-J. | - |
dc.contributor.author | Jo, D.S. | - |
dc.contributor.author | Kim, Y.K. | - |
dc.contributor.author | Eun, B.W. | - |
dc.contributor.author | Lee, T.J. | - |
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Lee, H. | - |
dc.contributor.author | Kim, K.H. | - |
dc.contributor.author | Cho, H.-K. | - |
dc.contributor.author | Cho, E.Y. | - |
dc.contributor.author | Kim, J.-H. | - |
dc.date.accessioned | 2021-09-02T01:19:03Z | - |
dc.date.available | 2021-09-02T01:19:03Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1738-1061 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/70761 | - |
dc.description.abstract | The Committee on Infectious Diseases of the Korean Pediatric Society recommended immunization schedule for children and adolescents aged 18 years or younger in the 9th (2018) edition of Immunization guideline. This report provides the revised recommendations made by the committee and summarizes several changes from the 2015 guideline. National immunization program (NIP) launched a human papillomavirus (HPV) immunization for girls aged 12 years in 2016. NIP has also expanded age indication for inactivated influenza vaccine (IIV) to 12 years of age in the 2018-2019 season. Quadrivalent IIVs with a full dose (0.5 mL) are approved for all children of 6 months or older. Recommendations of live attenuated influenza vaccine were removed. For inactivated Japanese encephalitis vaccine, first 2 doses are considered as the primary series. Recommendations for use of newly introduced vaccines (diphtheria-tetanus-acellular pertussis/inactivated poliovirus/Haemophilus influenzae type b, 9-valent HPV, new varicella vaccine, new quadrivalent IIV, and attenuated oral typhoid vaccine) were added. Lastly, monitoring system for adverse events following immunization was updated. Other changes can be found in the 9th edition of Immunization guideline in detail. © 2019 by The Korean Pediatric Society. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Pediatric Society | - |
dc.subject | chickenpox vaccine | - |
dc.subject | diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b vaccine | - |
dc.subject | diphtheria pertussis tetanus vaccine | - |
dc.subject | dtap | - |
dc.subject | gc flu | - |
dc.subject | influenza vaccine | - |
dc.subject | Japanese encephalitis vaccine | - |
dc.subject | Pneumococcus vaccine | - |
dc.subject | poliomyelitis vaccine | - |
dc.subject | Rotavirus vaccine | - |
dc.subject | sky varicella | - |
dc.subject | typhoid vaccine | - |
dc.subject | Wart virus vaccine | - |
dc.subject | child | - |
dc.subject | diphtheria | - |
dc.subject | encephalitis | - |
dc.subject | human | - |
dc.subject | immunization | - |
dc.subject | influenza | - |
dc.subject | Japanese encephalitis | - |
dc.subject | pertussis | - |
dc.subject | Review | - |
dc.subject | tetanus | - |
dc.subject | typhoid fever | - |
dc.subject | vaccination | - |
dc.subject | Wart virus | - |
dc.title | Recommended immunization schedule for children and adolescents: Committee on infectious diseases of the korean pediatric society, 2018 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Y.K. | - |
dc.identifier.doi | 10.3345/kjp.2019.00227 | - |
dc.identifier.scopusid | 2-s2.0-85071235042 | - |
dc.identifier.bibliographicCitation | Korean Journal of Pediatrics, v.62, no.7, pp.252 - 256 | - |
dc.relation.isPartOf | Korean Journal of Pediatrics | - |
dc.citation.title | Korean Journal of Pediatrics | - |
dc.citation.volume | 62 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 252 | - |
dc.citation.endPage | 256 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002487767 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | chickenpox vaccine | - |
dc.subject.keywordPlus | diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b vaccine | - |
dc.subject.keywordPlus | diphtheria pertussis tetanus vaccine | - |
dc.subject.keywordPlus | dtap | - |
dc.subject.keywordPlus | gc flu | - |
dc.subject.keywordPlus | influenza vaccine | - |
dc.subject.keywordPlus | Japanese encephalitis vaccine | - |
dc.subject.keywordPlus | Pneumococcus vaccine | - |
dc.subject.keywordPlus | poliomyelitis vaccine | - |
dc.subject.keywordPlus | Rotavirus vaccine | - |
dc.subject.keywordPlus | sky varicella | - |
dc.subject.keywordPlus | typhoid vaccine | - |
dc.subject.keywordPlus | Wart virus vaccine | - |
dc.subject.keywordPlus | child | - |
dc.subject.keywordPlus | diphtheria | - |
dc.subject.keywordPlus | encephalitis | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | immunization | - |
dc.subject.keywordPlus | influenza | - |
dc.subject.keywordPlus | Japanese encephalitis | - |
dc.subject.keywordPlus | pertussis | - |
dc.subject.keywordPlus | Review | - |
dc.subject.keywordPlus | tetanus | - |
dc.subject.keywordPlus | typhoid fever | - |
dc.subject.keywordPlus | vaccination | - |
dc.subject.keywordPlus | Wart virus | - |
dc.subject.keywordAuthor | Adolescent | - |
dc.subject.keywordAuthor | Child | - |
dc.subject.keywordAuthor | Immunization schedule | - |
dc.subject.keywordAuthor | Infant | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.